Cardiovascular Systems Issues Earnings Results
CSIIDelisted Stock | USD 20.00 0.00 0.00% |
Under 56% of Cardiovascular Systems' investor base is looking to short. The analysis of current outlook of investing in Cardiovascular Systems suggests that many traders are alarmed regarding Cardiovascular Systems' prospects. Cardiovascular Systems' investing sentiment shows overall attitude of investors towards Cardiovascular Systems.
Cardiovascular |
Cardiovascular Systems issued its earnings results on Wednesday. The medical device company reported earnings per share for the quarter, missing analysts consensus estimates of by , Briefing.com reports. Cardiovascular Systems had a negative net margin of 16.40 percent and a negative return on equity of 15.51. The company had
Read at thelincolnianonline.com
Cardiovascular Systems Fundamental Analysis
We analyze Cardiovascular Systems' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardiovascular Systems using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardiovascular Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Cardiovascular Systems is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Cardiovascular Systems Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cardiovascular Systems stock to make a market-neutral strategy. Peer analysis of Cardiovascular Systems could also be used in its relative valuation, which is a method of valuing Cardiovascular Systems by comparing valuation metrics with similar companies.
Peers
Cardiovascular Systems Related Equities
ESTA | Establishment Labs | 7.49 | ||||
NARI | Inari Medical | 5.74 | ||||
MXCT | MaxCyte | 5.73 | ||||
GKOS | Glaukos Corp | 4.71 | ||||
LIVN | LivaNova PLC | 2.90 | ||||
ITGR | Integer Holdings | 0.70 | ||||
CVRX | CVRx | 0.37 | ||||
KIDS | Orthopediatrics Corp | 0.22 | ||||
OFIX | Orthofix Medical | 0.11 | ||||
SGHT | Sight Sciences | 0.26 | ||||
BRKR | Bruker | 0.55 | ||||
FNA | Paragon 28 | 0.57 | ||||
NVRO | Nevro Corp | 0.69 | ||||
TMCI | Treace Medical | 0.89 | ||||
CNMD | CONMED | 1.94 | ||||
SIBN | Si Bone | 2.61 | ||||
RPID | Rapid Micro | 2.88 | ||||
NPCE | Neuropace | 3.74 | ||||
OM | Outset Medical | 4.65 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Consideration for investing in Cardiovascular Stock
If you are still planning to invest in Cardiovascular Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Cardiovascular Systems' history and understand the potential risks before investing.
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |